Cassava Sciences, Inc. (FLNA) vs NanoViricides, Inc. (NNVC)

Cassava Sciences, Inc. and NanoViricides, Inc. are both Biotechnology companies. Cassava Sciences, Inc. and NanoViricides, Inc. are of similar size ($38.0M and $37.8M). Across the 9 metrics below, NanoViricides, Inc. leads on 5 and Cassava Sciences, Inc. on 4.

Valuation

Metric FLNA NNVC Biotechnology median
P/E n/m n/m 7.88
P/S n/m n/m 11.47
P/B 0.57 3.40 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA 1.03 n/m 0.74
EV/Sales n/m n/m 10.73
Earnings yield (116.00%) (29.86%) (28.84%)
Free cash flow yield (81.04%) (23.69%) (23.03%)

Profitability

Metric FLNA NNVC Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (55.78%) (89.97%) (57.72%)
Return on assets (35.34%) (79.91%) (49.22%)
Return on invested capital 0.00% (86.02%) 0.00%

Growth

Metric FLNA NNVC Biotechnology median
Revenue growth (TTM) 277.58% — 5.64%
EPS growth (last fiscal year) (259.95%) 10.00% —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric FLNA NNVC Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 2.08 3.17 4.73
Net debt to EBITDA 1.01 0.18 0.96

Dividend

Metric FLNA NNVC Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric FLNA NNVC Biotechnology median
Market cap 37.79m 38.04m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack